Biote Corp (BTMD)

• Market cap: $107M
• 1 day: -1.74%
• 5 days: 2.42%
• 1 month: 12.25%
• 3 months: -14.82%
• 6 months: -15.25%
• Year to date: -43.78%
• 1 year: -42.64%
• 5 years: -66.27%
• 10 years: -66.27%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Employees: 217

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

24% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 29

6% more funds holding

Funds holding: 89 [Q1] → 94 (+5) [Q2]

1.99% less ownership

Funds ownership: 52.0% [Q1] → 50.01% (-1.99%) [Q2]

27% less capital invested

Capital invested by funds: $90.5M [Q1] → $66.5M (-$24M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $4
• Avg. target: $4
• High target: $4

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

B. Riley Securities Jeff Van Sinderen

$4

Neutral Downgraded

7 Aug 2025